{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T07:39:39Z","timestamp":1713339579532},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,26]]},"DOI":"10.7759\/cureus.23520","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T19:55:08Z","timestamp":1648324508000},"source":"Crossref","is-referenced-by-count":2,"title":["Nitrates as a Marker of Multiple Co-morbidities and Increased Mortality in Patients Undergoing Percutaneous Coronary Intervention (PCI)"],"prefix":"10.7759","author":[{"given":"Neil","family":"Yager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunjeev","family":"Konduru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Torosoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin EJ","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al.. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019, 139:56-528. 10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.08.002","article-title":"2007 chronic angina focused update of the ACC\/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina","volume":"50","author":"Fraker TD","year":"2007","unstructured":"Fraker TD, Fihn SD. 2007 chronic angina focused update of the ACC\/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007, 50:2264-74. 10.1016\/j.jacc.2007.08.002","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000047041.66447.29","article-title":"ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina)","volume":"107","author":"Gibbons RJ","year":"2003","unstructured":"Gibbons RJ, Abrams J, Chatterjee K, et al.. ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003, 107:149-58. 10.1161\/01.cir.0000047041.66447.29","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: a 'diamond' approach to personalized treatment of angina","volume":"15","author":"Ferrari R","year":"2018","unstructured":"Ferrari R, Camici PG, Crea F, et al.. Expert consensus document: a 'diamond' approach to personalized treatment of angina. Nat Rev Cardiol. 2018, 15:120-32. 10.1038\/nrcardio.2017.131","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti J","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al.. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020, 41:407-77. 10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari R","year":"2019","unstructured":"Ferrari R, Pavasini R, Camici PG, et al.. Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment. Eur Heart J. 2019, 40:190-4. 10.1093\/eurheartj\/ehy504","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182776f83","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"126","author":"Fihn SD","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, et al.. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012, 126:3097-137. 10.1161\/CIR.0b013e3182776f83","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suaa060","article-title":"Treatment of stable ischaemic heart disease: the old and the new","volume":"22","author":"Santucci A","year":"2020","unstructured":"Santucci A, Riccini C, Cavallini C. Treatment of stable ischaemic heart disease: the old and the new. Eur Heart J Suppl. 2020, 22:54-9. 10.1093\/eurheartj\/suaa060","journal-title":"Eur Heart J Suppl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot G","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, et al.. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013, 34:2949-3003. 10.1093\/eurheartj\/eht296","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, 373:2117-28. 10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(99)70163-8","article-title":"Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies","volume":"138","author":"Nakamura Y","year":"1999","unstructured":"Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C, Multicenter Myocardial Ischemia Research Group. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Am Heart J. 1999, 138:577-85. 10.1016\/s0002-8703(99)70163-8","journal-title":"Am Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.60.779","article-title":"Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction","volume":"60","author":"Ishikawa K","year":"1996","unstructured":"Ishikawa K, Kanamasa K, Ogawa I, et al.. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J. 1996, 60:779-88. 10.1253\/jcj.60.779","journal-title":"Jpn Circ J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/000331970205300405","article-title":"Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients","volume":"53","author":"Kanamasa K","year":"2002","unstructured":"Kanamasa K, Hayashi T, Kimura A, Ikeda A, Ishikawa K. Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients. Angiology. 2002, 53:399-408. 10.1177\/000331970205300405","journal-title":"Angiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine MS","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, et al.. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017, 376:1713-22. 10.1056\/NEJMoa1615664","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22594","article-title":"Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease","volume":"39","author":"Shen L","year":"2016","unstructured":"Shen L, Vavalle JP, Broderick S, Shaw LK, Douglas PS. Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease. Clin Cardiol. 2016, 39:721-7. 10.1002\/clc.22594","journal-title":"Clin Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007526","article-title":"Variations in use of optimal medical therapy in patients with nonobstructive coronary artery disease: a population-based study","volume":"6","author":"Oxner A","year":"2017","unstructured":"Oxner A, Elbaz-Greener G, Qui F, et al.. Variations in use of optimal medical therapy in patients with nonobstructive coronary artery disease: a population-based study. J Am Heart Assoc. 2017, 6:e007526. 10.1161\/JAHA.117.007526","journal-title":"J Am Heart Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.10.005","article-title":"ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography","volume":"53","author":"Patel MR","year":"2009","unstructured":"Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009, 53:530-53. 10.1016\/j.jacc.2008.10.005","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden WE","year":"2007","unstructured":"Boden WE, O'Rourke RA, Teo KK, et al.. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007, 356:1503-16. 10.1056\/NEJMoa070829","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron DJ","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, et al.. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020, 382:1395-407. 10.1056\/NEJMoa1915922","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-2517-9_2","article-title":"Evidence in guidelines for treatment of coronary artery disease","volume":"1177","author":"Jia S","year":"2020","unstructured":"Jia S, Liu Y, Yuan J. Evidence in guidelines for treatment of coronary artery disease. Adv Exp Med Biol. 2020, 1177:37-73. 10.1007\/978-981-15-2517-9_2","journal-title":"Adv Exp Med Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430040023003","article-title":"The role of nitrates in coronary heart disease","volume":"155","author":"Abrams J","year":"1995","unstructured":"Abrams J. The role of nitrates in coronary heart disease. Arch Intern Med. 1995, 155:357-64. 10.1001\/archinte.1995.00430040023003","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1990.258.2.H515","article-title":"Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin","volume":"258","author":"Sellke FW","year":"1990","unstructured":"Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol. 1990, 258:515-20. 10.1152\/ajpheart.1990.258.2.H515","journal-title":"Am J Physiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance","volume":"97","author":"M\u00fcnzel T","year":"2005","unstructured":"M\u00fcnzel T, Daiber A, M\u00fclsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005, 97:618-28. 10.1161\/01.RES.0000184694.03262.6d","journal-title":"Circ Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112024","article-title":"N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin","volume":"76","author":"Loscalzo J","year":"1985","unstructured":"Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest. 1985, 76:703-8. 10.1172\/JCI112024","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90232-1","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction","volume":"343","author":"Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico","year":"1994","unstructured":"Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994, 343:1115-22. 10.1016\/S0140-6736(94)90232-1","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","author":"The Multicenter Diltiazem Postinfarction Trial Research Group","year":"1988","unstructured":"The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988, 319:385-92. 10.1056\/NEJM198808183190701","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-52","article-title":"Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention","volume":"10","author":"Yiu KH","year":"2011","unstructured":"Yiu KH, Pong V, Siu CW, Lau CP, Tse HF. Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention. Cardiovasc Diabetol. 2011, 10:52. 10.1186\/1475-2840-10-52","journal-title":"Cardiovasc Diabetol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29368","article-title":"Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease","volume":"98","author":"Yager N","year":"2021","unstructured":"Yager N, Schulman-Marcus J, Torosoff M. Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease. Catheter Cardiovasc Interv. 2021, 98:436-44. 10.1002\/ccd.29368","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys PW","year":"2009","unstructured":"Serruys PW, Morice MC, Kappetein AP, et al.. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009, 360:961-72. 10.1056\/NEJMoa0804626","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright JT Jr","year":"2015","unstructured":"Wright JT Jr, Williamson JD, Whelton PK, et al.. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015, 373:2103-16. 10.1056\/NEJMoa1511939","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90871-nitrates-as-a-marker-of-multiple-co-morbidities-and-increased-mortality-in-patients-undergoing-percutaneous-coronary-intervention-pci","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:17Z","timestamp":1707507797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90871-nitrates-as-a-marker-of-multiple-co-morbidities-and-increased-mortality-in-patients-undergoing-percutaneous-coronary-intervention-pci"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.23520","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,26]]}}}